An increased reporting of shigellosis cases, mainly caused by Shigella sonnei, among travellers returning from Cabo Verde has been ongoing in the European Union/European Economic Area (EU/EEA), the United Kingdom (UK), and the United States (US) since September 2022. This outbreak evolved rapidly during November and December 2022.
This document assesses the risk of further spread of S. sonnei amongst MSM and in the broader population in EU/EEA countries, resulting from the current increase in extensively-drug resistant S. sonnei infections.
As of 30 August 2018, Algeria has reported 74 confirmed cholera cases from six northern and coastal areas of the country. This is the first cholera outbreak reported in Algeria in more than 20 years.
Following the occurrence of several hospital-acquired malaria cases in the European Union (EU), ECDC has assessed the risk related to transmission of the parasite in hospital settings.
The production of this rapid risk assessment was triggered by a report by the Czech Republic of two travelassociated cases of cholera from Zanzibar (Tanzania) and the cholera epidemics in the Horn of Africa and the Gulf of Aden.
The occurrence of shigellosis among refugees is not unexpected because shigellosis is endemic in the countries they originate from, as well as in some of the countries they travel through.
This rapid risk assessment assesses the specific risk related to importation and spread of vector borne diseases in the context of a large number of migrants to the EU. It does not cover other health needs for these populations.
Locally acquired cases of malaria have been occurring in Greece since 2009, with the highest numbers reported in 2011. In 2012, local malaria transmission was still ongoing, but fewer cases were reported.
This updated rapid risk assessment assesses the potential risk for European travellers to Cuba after an outbreak of cholera in the Cuban province of Granma expanded to the provinces of Santiago de Cuba, Camagüey and Guantanamo.